Juxtarenal Abdominal Aortic Aneurysm Clinical Trial
Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm: A Prospective, Single Arm, Multi-center, Objective Performance Criteria Clinical Trial
A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of WeFlow-JAAA stent graft system manufactured by Hangzhou Endonom Medtech Co., Ltd. for the complex abdominal aortic aneurysm.
|Source||Hangzhou Endonom Medtech Co., Ltd.|
|Status||Not yet recruiting|
|Start date||January 1, 2022|
|Completion date||November 1, 2023|